BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23359388)

  • 21. Estrogen receptor-beta expression in human testicular germ cell tumors.
    Pais V; Leav I; Lau KM; Jiang Z; Ho SM
    Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
    Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
    J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
    Bezan A; Gerger A; Pichler M
    Anticancer Res; 2014 Jun; 34(6):2709-13. PubMed ID: 24922631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
    Emanuel PO; Unger PD; Burstein DE
    Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
    Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
    Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCPH expression is an early event in the development of testicular germ cell tumors.
    Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
    Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glypican 3: a novel marker in testicular germ cell tumors.
    Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
    Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in the pathology of germ cell tumors.
    Ulbright TM; Roth LM
    Semin Diagn Pathol; 1987 Nov; 4(4):304-19. PubMed ID: 2832917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors.
    Liu J; Ye M; Han R; Gui Y; Li X; Zhang H; Wang X; Guo H; Li F; Zhao AZ; Guan K; Chen H
    Med Oncol; 2019 May; 36(7):61. PubMed ID: 31140031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets.
    Chieffi P; De Martino M; Esposito F
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):189-195. PubMed ID: 32164473
    [No Abstract]   [Full Text] [Related]  

  • 33. Testicular germ cell tumors: biology and clinical update.
    Nallu A; Mannuel HD; Hussain A
    Curr Opin Oncol; 2013 May; 25(3):266-72. PubMed ID: 23549473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPR30 is overexpressed in post-puberal testicular germ cell tumors.
    Franco R; Boscia F; Gigantino V; Marra L; Esposito F; Ferrara D; Pariante P; Botti G; Caraglia M; Minucci S; Chieffi P
    Cancer Biol Ther; 2011 Mar; 11(6):609-13. PubMed ID: 21278491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
    Cheng CJ; Wu YC; Shu JA; Ling TY; Kuo HC; Wu JY; Chang EE; Chang SC; Huang YH
    J Biomed Sci; 2007 Nov; 14(6):797-807. PubMed ID: 17682839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-G in testicular germ cell tumors.
    Karagöz B; Haholu A; Ozgün A; Bilgi O; Tunçel T; Emirzeoğlu L; Celik S; Demirel D
    Oncol Res Treat; 2014; 37(5):245-8. PubMed ID: 24853783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-cell tumors of the mediastinum.
    Weidner N
    Semin Diagn Pathol; 1999 Feb; 16(1):42-50. PubMed ID: 10355653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
    Bu L; Yang Q; McMahon L; Xiao GQ; Li F
    Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma.
    Cao D; Lane Z; Allan RW; Wang P; Guo CC; Peng Y; Li J
    Histopathology; 2010 Jul; 57(1):152-7. PubMed ID: 20553335
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
    Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.